Summary:
A Korean R&D institute specialised in ICT Bio-healthcare has developed ultrasonic wireless power transfer technology, which is more biocompatible than the primary battery used in conventional implantable medical devices and using this technology, bio-signal sensing and bio-stimulating devices have been also developed. Any organisation in need of such a technology can be a potential partner under the license agreement, technical cooperation and commercial agreement with technical assistance.
Description:
Implementable medical devices have been widely used such as Deep Brain Neuro Stimulator, Cochlear Implants, Implantable Cardiac Defibrillator or Insulin Pump to help restore or recover body functions damaged by ageing, disease, unexpected accidents or etc.
However, these implantable medical devices cause patients to be exposed to the high risk of infection by primary battery-based power supplies and to feel uncomfortable, psychological pressure due to the frequent revision surgery of replacing the power supply. Thus, a number of ways to transfer power wirelessly have been recently developed using electromagnetic induction, magnetic resonance or ultrasound.
A Korean R&D institute focusing on ICT Bio-healthcare has developed an implementable device employing ultrasonic wireless power transfer technology.
The advantages and innovations are as below.
1) Able to supply power continuously using ultrasonic power transmission
2) Able to build an all-in-one device with integrating ultrasonic wireless power transfer, low-power data communication technology and bio-signal sensing technology
3) Lower inflammation index than 1.5 by packaging the entire device using biocompatible materials
The device consists of detailed technologies.
1) Ultrasonic wireless charging
2) Low-power Bluetooth
3) Wireless battery Charging monitoring and circuit protection
4) Bio-signal processing
5) Biocompatible packaging
6) Nerve stimulating signal process circuit
Any companies or research institutes, related in implantable medical device area, can be the potential partners under the license agreement, technical cooperation and commercial agreement with technical assistance.
Type (e.g. company, R&D institution…), field of industry and Role of Partner Sought:
- Any company, which is a provider of R&D service including animal testing or a manufacturer of implementable medical devices, interested in the technology can be a partner under the license agreement, technical cooperation and commercial agreement with technical assistance.
- Any company or institute interested in joint R&D of Brain-Computer Interface currently being conducted by the Korean R&D institute.
Stage of Development:
Field tested/evaluated
IPR Status:
Secret Know-how,Patents granted
Comments Regarding IPR Status:
- Wireless power transmission apparatus using ultrasound / USA / 2016
- Bio-stimulating and bio-signal measuring circuit / USA / 2019
External code:
TOKR20201209002